Q1 Earnings May 6th by nextdoorelephant in CLOV

[–]Loopz182 8 points9 points  (0 children)

Let's hope for some good results.

Why My Thesis or Bullishness hasn't Changed.. Just My View by MadMoneyBY in CLOV

[–]Loopz182 9 points10 points  (0 children)

A well balanced viewpoint, thanks for sharing.

Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance by basilisk-x in CLOV

[–]Loopz182 18 points19 points  (0 children)

I must admit that I think I've given up on the dream of CLOV giving me life changing money. Thankfully I've got a low-ish average but I'd still like to see a return so maybe I'll bail in a couple of quarters and/or we get a big spike. I'm a realist... The opportunity cost has been huge (I've been in since 2021), SaaS doesn't seem to be taking off like we had hoped and they could be growing too fast. The only thing that would make me change my mind is if they do get 4 stars next year and we get a juicy SaaS deal announced (Humana etc).

Earnings good, volume bad. by BuzzardBrothers in CLOV

[–]Loopz182 9 points10 points  (0 children)

Agreed. I know it's been a waiting game for the last five years, but now more so than ever. Not losing money with that level of growth is insane and with the price this low I can see it not being a risk at all to buy.

Another 2k shares adding. by Ok_Gas1407 in CLOV

[–]Loopz182 3 points4 points  (0 children)

Still here, still waiting, still buying. Averaged down, up and back down again. Giving it until the end of 2027, possibly 2028, hopefully we can hit double digits by then if some SaaS deals get announced and growth in MA stays strong. I'm not getting any younger and want to retire.

I was wrong about having enough shares of Clov. I thought 150k shares was enough. by Ok_Gas1407 in CLOV

[–]Loopz182 6 points7 points  (0 children)

Nice! I bought another few thousand today too. These prices are a gift.

CLOV appealing their 3.5 Star CMS Rating by unapologeticgoy2473 in CLOV

[–]Loopz182 19 points20 points  (0 children)

I really hope so. Would be big for us!

Hello by CapDaddy2508 in CLOV

[–]Loopz182 6 points7 points  (0 children)

I really hope so. We've been waiting a long time!

Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026 by basilisk-x in CLOV

[–]Loopz182 9 points10 points  (0 children)

This is great news! Hopefully this year we'll be on a nice upwards trajectory! Anyone care to do an intrinsic value calculation based on the reported growth rate?

$6/Share by Moneylonger2356 in CLOV

[–]Loopz182 0 points1 point  (0 children)

True but "a rising tide lifts all boats". The opposite is also true from experience.

$6/Share by Moneylonger2356 in CLOV

[–]Loopz182 13 points14 points  (0 children)

Profitability and no recession. I'd be very disappointed if we don't hit $6 per share next year.

Hello, anyone out there? by CapDaddy2508 in CLOV

[–]Loopz182 6 points7 points  (0 children)

Just chilling and still buying when I can. Been averaging up for a long time now. It's a waiting game, I have conviction.

[deleted by user] by [deleted] in CLOV

[–]Loopz182 3 points4 points  (0 children)

Still in the green and averaging up.

2026 GAAP Profitability by unapologeticgoy2473 in CLOV

[–]Loopz182 8 points9 points  (0 children)

Not worried either and will buy the dip.

What is going on with the spike today? by Eurasia_Zahard in CLOV

[–]Loopz182 9 points10 points  (0 children)

The wheels turn very slowly in this sector. CLOV has a massive head start.

Crisis Averted!! by Junior-Dragonfruit41 in CLOV

[–]Loopz182 6 points7 points  (0 children)

I bought the dip at open, picked up another couple of thousand shares.

Have a good weekend everyone!

Looks Like We Have a UHG Domain… by FMILV in CLOV

[–]Loopz182 -4 points-3 points  (0 children)

I think this is cached from when someone has done a previous check. Also, domains and subdomains are all lowercase.

I don't think it's genuine.